Trial Profile
A 12-Week Open-Label Study Followed By A 24-Week Double-Blind Discontinuation Exploratory Study To Evaluate The Effects Of Gabitril (Tiagabine Hydrochloride) In Patients With Social Anxiety Disorder (SAD).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Apr 2009
Price :
$35
*
At a glance
- Drugs Tiagabine (Primary)
- Indications Social phobia
- Focus Therapeutic Use
- 25 Aug 2006 New trial record.